ScienceResults Jul 2
Will the FDA approve Viridian Therapeutics’ veligrotug for thyroid eye disease by June 30, 2026?
45%
Stable · last 24h
📊 0 bettors💎 0 at stake
🤖 Context
YES if the FDA issues approval for veligrotug to treat thyroid eye disease (TED) by U.S. FDA decision date June 30 2026 (inclusive); NO otherwise.
🔍 Sources
Sources used to resolve this market
💬 0 comments
Add your take...No comments yet. Start the conversation!